The australian arthroplasty thromboprophylaxis survey

Journal of Arthroplasty

Volumn 27, Issue 2, 2012, Pages 173-179

  Molnar, Robert B ^a,b   Jenkin, Deanne E ^a   Millar, Michael J ^a   Campbell, David ^c   Harris, Ian A ^a,b,d  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Wakefield Orthopaedic Clinic   (Australia)

^d LIVERPOOL HOSPITAL   (Australia)

Author keywords

Anticoagulants; Thromboprophylaxis; Total joint replacement; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; AUSTRALIA; COMPRESSION GARMENT; HEALTH SURVEY; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; LAW SUIT; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MOBILIZATION; ORTHOPEDIC SURGEON; PRACTICE GUIDELINE; PROCEDURES; PROPHYLAXIS; QUESTIONNAIRE; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; ASPIRIN; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; DATA COLLECTION; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MOTION THERAPY, CONTINUOUS PASSIVE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK FACTORS; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 84855542745     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2011.05.003     Document Type: Article

References (30)

1. Australian Orthopaedic Association national joint replacement registry 2009 Available at. http://www.dmac.adelaide.edu.au/aoanjrr/publications.jsp?section=reports.
2. Nicolaides A.N., et al. International consensus statement. Angiol 2006, 25:101.
3. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence Base Clinical Practice Guidelines (8th Edition). Chest 2008, 133(6 suppl):381S.
4. NICE Clinical Guideline. Venous thromboembolism reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing surgery Available at. http://www/guidance.nice.org.uk/CG46/nice-guidance/pdf/English.
5. SIGN 2002. Prophylaxis of venous thromboembolism. SIGN Guideline No. 62 ISBN 18998993 03.2. Available at. http://www.sign.ac.uk/guidlines/fulltext/62/index.html.
6. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism (PEP) trial. Lancet 2000, 355:1295. PEP Trial Collaborative Group.
7. American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total hip or Knee Arthroplasty Adopted by the American Academy of Orthopedic Surgeons Board of Directors May 2007 Available at. http://www.aaos.org/research/guidelines/PE_guideline.pdf.
8. Total hip replacement: a guide to best practice 1998, British Orthopaedic Association, BOA, London.
9. Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism. Prevention of venous thromboembolism: best practice guidelines for Australia and New Zealand 2007, Health Education and Management Innovations, Sydney. 4th ed.
10. Warwick D., Dahl O.E., Fisher W.D. Orthopaedic thromboprophylaxis: limitations of current guidelines. J Bone Joint Surg (Br) 2008, 90B:127.
11. Amstutuz H.C., Dorey F.J. Are recommendations for the routine use of pharmacological thromboprophylaxis in total hip arthroplasty justified?. J Bone Joint Surg (Br) 2000, 82B:473.
12. Rodgers A., Gray H., MacMahon S. Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons. ANZ J Surg 1994, 64:167.
13. Walker N., Rodgers A., Gray H. Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand. ANZ J Surg 2002, 72:335.
14. Gross M., Anderson D.R., Nagpal S., et al. Venous thromboembolism prophylaxis after total hip or knee arthroplasty: a survey of Canadian orthopedic surgeons. Can J Surg 1999, 42:457.
15. Francis R.M., Brenkel I.J. Survey of use of thromboprophylaxis for routine total hip replacement by British orthopaedic surgeons. Br J Hosp Med 1997, 57:427.
16. Janku G.V., Paiement G.D., Green H.D. Prevention of venous thromboembolism in orthopaedics in the United States. Clinl Orthop Rel Res 1996, 325:313.
17. Ettema H.B., et al. Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey. Acta Orthop 2009, 80:109.
18. Sharrock N.E., Della Valle A.G., Go G., et al. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Rel Res 2008, 466:714.
19. Ryan M.G., Westrich G.H., Potter H.G., et al. Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography. J Bone Joint Surg Am 2002, 84A:1998.
20. Lachiewicz P.F., Kelley S.S., Haden L.R. Two mechanical devices for prophylaxis of thromboembolism after total knee arthroplasty: a prospective, randomised study. J Bone Joint Surg Br 2004, 86B:1137.
21. Pitto R.P., Hamer H., Heiss-Dunlop W., et al. Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial. J Bone Joint Surg Br 2004, 86B:639.
22. Howie C., Hughes H., Watts A.C. Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study. J Bone Joint Surg Br 2005, 87:1675.
23. Kessler D.P., Summerton N., Graham J.R. Effects of the medical liability system in Australia, the UK, and the USA. Lancet 2006, 368:240.
24. Millar J. Genesis of medical thromboprophylaxis guidelines in Australia: a need for transparency and standardisation inguideline development. Med J Aust 2009, 190:446.
25. National Health and Medical Research Council A guide to the development, implementation and evaluation of clinical practice guidelines 1999, NHMRC, Canberra, (accessed Jan 2010). http://www.nhmrc.gov.au/publications/synopses/cp30syn.htm.
26. Ettema H.B., et al. Compliance of Dutch orthopedic departments with national guidelines on thromboprophylaxis: a survey of Dutch orthopedic thromboprophylaxis. Acta Orthop 2005, 76:99.
27. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004, 126(Suppl):338.
28. Eikelboom J.W., Karthikeyan G., Fagel N., et al. American association of orthopaedic surgeons and American college of chest physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?. Chest 2009, 135:513.
29. Abraham A., Hajipour L., Innes A.R., et al. Are national guidelines for total hip replacement in the UK reflected in practice?. Ann R Coll Surg Engl 2006, 88:108.
30. Parry M., Wylde V., Blom A.W. Ninety-day mortality after elective total hip replacement: 1549 patients using aspirin as a thromboprophylactic agent. J Bone Joint Surg Br 2008, 90:306.